THE United Kingdom’s drug regulator said today it has approved an updated Covid-19 jab by Pfizer-BioNTEch targeting the original virus and a subvariant ahead of an autumn booster drive.
The so-called “bivalent” jabs work for both the original virus that emerged in the Chinese city of Wuhan in 2019 and the BA.1 subvariant of Omicron.
Effective July 2018, access to full reports will only be available with a subscription. Sign-up now and enjoy one (1) week free access!
Comments